Comparison of Somatostatin Analogue (SA) and Chemotherapy (CT) in Neuroendocrine Tumors (NET) Patients with Ki-67 ?20%
dc.authorid | Tanriverdi, Ozgur/0000-0002-0598-7284 | |
dc.authorid | Hacioglu, Bekir/0000-0001-8490-3239 | |
dc.authorid | Uysal, Mukremin/0000-0002-8524-0665 | |
dc.authorid | duran, Ayse Ocak/0000-0002-1703-726X; | |
dc.authorwosid | Tanriverdi, Ozgur/M-2172-2015 | |
dc.authorwosid | ozcelik, melike/AAS-7557-2020 | |
dc.authorwosid | ÖZASLAN, ERSİN/V-3556-2017 | |
dc.authorwosid | Hacioglu, Bekir/GZH-1824-2022 | |
dc.authorwosid | Sevinc, Alper/KFQ-6440-2024 | |
dc.authorwosid | Uysal, Mukremin/B-8956-2014 | |
dc.authorwosid | duran, Ayse Ocak/ABA-7090-2021 | |
dc.contributor.author | Ozaslan, E. | |
dc.contributor.author | Koca, S. | |
dc.contributor.author | Sevinc, A. | |
dc.contributor.author | Hacioglu, B. | |
dc.contributor.author | Ozcelik, M. | |
dc.contributor.author | Duran, A. O. | |
dc.contributor.author | Yildiz, Y. | |
dc.date.accessioned | 2024-06-12T11:15:25Z | |
dc.date.available | 2024-06-12T11:15:25Z | |
dc.date.issued | 2016 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description | 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease -- MAR 09-11, 2016 -- Barcelona, SPAIN | en_US |
dc.description.abstract | [Abstract Not Available] | en_US |
dc.description.sponsorship | ENETS | en_US |
dc.identifier.endpage | 74 | en_US |
dc.identifier.issn | 0028-3835 | |
dc.identifier.issn | 1423-0194 | |
dc.identifier.startpage | 74 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/23925 | |
dc.identifier.volume | 103 | en_US |
dc.identifier.wos | WOS:000386481600195 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Karger | en_US |
dc.relation.ispartof | Neuroendocrinology | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Somatostatin Analogue | en_US |
dc.subject | NET | en_US |
dc.subject | Ki-67 | en_US |
dc.title | Comparison of Somatostatin Analogue (SA) and Chemotherapy (CT) in Neuroendocrine Tumors (NET) Patients with Ki-67 ?20% | en_US |
dc.type | Conference Object | en_US |